Unexplained infertility

Affiliations

¹ The Center for Human Reproduction, New York, NY 10021, USA; Stem Cell Biology and Molecular Embryology Laboratory, The Rockefeller University, New York, NY, USA; Department of Obstetrics and Gynecology, Vienna University of Medicine, Vienna, Austria. Electronic address: ngleicher@thechr.com.
² The Center for Human Reproduction, New York, NY 10021, USA; Department of Obstetrics and Gynecology, Wake Forest University, Winston Salem, NC, USA.
³ Department of Obstetrics and Gynecology, Vienna University of Medicine, Vienna, Austria.

Comment

Norbert Gleicher et al. Lancet. 2018.

. 2018 Oct 27;392(10157):1516-1517.

doi: 10.1016/S0140-6736(18)31890-7.

¹ The Center for Human Reproduction, New York, NY 10021, USA; Stem Cell Biology and Molecular Embryology Laboratory, The Rockefeller University, New York, NY, USA; Department of Obstetrics and Gynecology, Vienna University of Medicine, Vienna, Austria. Electronic address: ngleicher@thechr.com.
² The Center for Human Reproduction, New York, NY 10021, USA; Department of Obstetrics and Gynecology, Wake Forest University, Winston Salem, NC, USA.
³ Department of Obstetrics and Gynecology, Vienna University of Medicine, Vienna, Austria.

No abstract available

Comment in

Unexplained infertility - Authors' reply.
Farquhar C. Farquhar C. Lancet. 2018 Oct 27;392(10157):1517. doi: 10.1016/S0140-6736(18)31885-3. Lancet. 2018. PMID: 30496057 No abstract available.

Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.
Farquhar CM, Liu E, Armstrong S, Arroll N, Lensen S, Brown J. Farquhar CM, et al. Lancet. 2018 Feb 3;391(10119):441-450. doi: 10.1016/S0140-6736(17)32406-6. Epub 2017 Nov 23. Lancet. 2018. PMID: 29174128 Clinical Trial.